Stephen L. Abrams

9.1k total citations · 1 hit paper
95 papers, 5.3k citations indexed

About

Stephen L. Abrams is a scholar working on Molecular Biology, Oncology and Information Systems. According to data from OpenAlex, Stephen L. Abrams has authored 95 papers receiving a total of 5.3k indexed citations (citations by other indexed papers that have themselves been cited), including 44 papers in Molecular Biology, 30 papers in Oncology and 18 papers in Information Systems. Recurrent topics in Stephen L. Abrams's work include PI3K/AKT/mTOR signaling in cancer (23 papers), Cancer-related Molecular Pathways (20 papers) and Research Data Management Practices (15 papers). Stephen L. Abrams is often cited by papers focused on PI3K/AKT/mTOR signaling in cancer (23 papers), Cancer-related Molecular Pathways (20 papers) and Research Data Management Practices (15 papers). Stephen L. Abrams collaborates with scholars based in United States, Italy and Poland. Stephen L. Abrams's co-authors include James A. McCubrey, Linda S. Steelman, Alberto M. Martelli, Massimo Libra, William H. Chappell, Jörg Bäsecke, Franca Stivala, Richard A. Franklin, Camilla Evangelisti and Michèle Milella and has published in prestigious journals such as SHILAP Revista de lepidopterología, Blood and Journal of Cellular Physiology.

In The Last Decade

Stephen L. Abrams

91 papers receiving 5.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Roles of the Raf/MEK/ERK pathway in cell growth, malignant transformation and drug resistance

2006 1.9k citations James A. McCubrey, Linda S. Steelman et al. Biochimica et Biophysica Acta (BBA) - Molecular Cell Research profile →

Peers

Countries citing papers authored by Stephen L. Abrams

Since Specialization

Citations

This map shows the geographic impact of Stephen L. Abrams's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stephen L. Abrams with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stephen L. Abrams more than expected).

Fields of papers citing papers by Stephen L. Abrams

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Stephen L. Abrams. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stephen L. Abrams. The network helps show where Stephen L. Abrams may publish in the future.

Co-authorship network of co-authors of Stephen L. Abrams

This figure shows the co-authorship network connecting the top 25 collaborators of Stephen L. Abrams. A scholar is included among the top collaborators of Stephen L. Abrams based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Stephen L. Abrams. Stephen L. Abrams is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Effects of the MDM2 inhibitor Nutlin-3a on sensitivity of pancreatic cancer cells to berberine and modified berberines in the presence and absence of WT-TP53 2021 ·Advances in Biological Regulation ·Stephen L. Abrams, Shaw M. Akula, Linda S. Steelman, (unknown), Lucio Cocco, Stefano Ratti, Alberto M. Martelli, Massimo Libra, Luca Falzone, Saverio Candido, Giuseppe Montalto, Melchiorre Cervello, Paolo Lombardi, James A. McCubrey	6
2	Cancer therapy and treatments during COVID-19 era 2020 ·Advances in Biological Regulation ·Shaw M. Akula, Stephen L. Abrams, Linda S. Steelman, Saverio Candido, Massimo Libra, (unknown), Lucio Cocco, Giulia Ramazzotti, Stefano Ratti, Matilde Y. Follo, Alberto M. Martelli, William L. Blalock, Manuela Piazzi, Giuseppe Montalto, Melchiorre Cervello, Monica Notarbartolo, Jörg Bäsecke, James A. McCubrey	33
3	GSK-3 and miRs: Master regulators of therapeutic sensitivity of cancer cells 2020 ·Biochimica et Biophysica Acta (BBA) - Molecular Cell Research ·Przemysław Duda, Shaw M. Akula, Stephen L. Abrams, Linda S. Steelman, Agnieszka Gizak, Dariusz Rakus, James A. McCubrey	15
4	RAS/RAF/MEK/ERK, PI3K/PTEN/AKT/mTORC1 and TP53 pathways and regulatory miRs as therapeutic targets in hepatocellular carcinoma 2019 ·Expert Opinion on Therapeutic Targets ·Shaw M. Akula, Stephen L. Abrams, Linda S. Steelman, Maria Rita Emma, Giuseppa Augello, Antonella Cusimano, Antonina Azzolina, Giuseppe Montalto, Melchiorre Cervello, James A. McCubrey	71
5	203.3 Nothing succeeds like success: A framework for evaluating digital preservation outcomes. 2018 ·Phaidra (Universität Wien) ·Stephen L. Abrams	1
6	Roles of p53, NF-κB and the androgen receptor in controlling NGAL expression in prostate cancer cell lines 2018 ·Advances in Biological Regulation ·William H. Chappell, Saverio Candido, Stephen L. Abrams, Suzanne Russo, Roger Ove, Alberto M. Martelli, Lucio Cocco, Giulia Ramazzotti, Melchiorre Cervello, Giuseppe Montalto, Linda S. Steelman, Xiaohong Leng, Ralph B. Arlinghaus, Massimo Libra, James A. McCubrey	19
7	Nothing succeeds like success: An approach for evaluating digital preservation efficacy 2018 ·eScholarship (California Digital Library) ·Stephen L. Abrams	1
8	Novel roles of androgen receptor, epidermal growth factor receptor, TP53, regulatory RNAs, NF-kappa-B, chromosomal translocations, neutrophil associated gelatinase, and matrix metalloproteinase-9 in prostate cancer and prostate cancer stem cells 2015 ·Advances in Biological Regulation ·William H. Chappell, Stephen L. Abrams, Kvin Lertpiriyapong, Timothy L. Fitzgerald, Alberto M. Martelli, Lucio Cocco, Dariusz Rakus, Agnieszka Gizak, David M. Terrian, Linda S. Steelman, James A. McCubrey	30
9	Roles of signaling pathways in drug resistance, cancer initiating cells and cancer progression and metastasis 2014 ·Advances in Biological Regulation ·James A. McCubrey, Stephen L. Abrams, Timothy L. Fitzgerald, Lucio Cocco, Alberto M. Martelli, Giuseppe Montalto, Melchiorre Cervello, Aurora Scalisi, Saverio Candido, Massimo Libra, Linda S. Steelman	102
10	Increased NGAL (Lnc2) expression after chemotherapeutic drug treatment 2012 ·Advances in Biological Regulation ·William H. Chappell, Stephen L. Abrams, Kristin M. Stadelman, Michelle M. LaHair, Richard A. Franklin, Lucio Cocco, Camilla Evangelisti, Francesca Chiarini, Alberto M. Martelli, Linda S. Steelman, James A. McCubrey	12
11	Ectopic NGAL expression can alter sensitivity of breast cancer cells to EGFR, Bcl-2, CaM-K inhibitors and the plant natural product berberine 2012 ·Cell Cycle ·William H. Chappell, Stephen L. Abrams, Richard A. Franklin, Michelle M. LaHair, Giuseppe Montalto, Melchiorre Cervello, Alberto M. Martelli, Ferdinando Nicoletti, Saverio Candido, Massimo Libra, Jerry Polesel, Renato Talamini, Michèle Milella, Agostino Tafuri, Linda S. Steelman, James A. McCubrey	21
12	Involvement of Akt and mTOR in chemotherapeutic- and hormonal-based drug resistance and response to radiation in breast cancer cells 2011 ·Cell Cycle ·Linda S. Steelman, Patrick M. Navolanic, William H. Chappell, Stephen L. Abrams, Ellis W.T. Wong, Alberto M. Martelli, Lucio Cocco, Franca Stivala, Massimo Libra, Ferdinando Nicoletti, Л. Б. Дробот, Richard A. Franklin, James A. McCubrey	70
13	Practices, Trends, and Recommendations in Technical Appendix Usage for Selected Data-Intensive Disciplines 2011 ·eScholarship (California Digital Library) ·John Kunze, (unknown), (unknown), Stephen L. Abrams, (unknown), (unknown), (unknown)	6
14	Roles of the Ras/Raf/MEK/ERK pathway in leukemia therapy 2011 ·Leukemia ·Linda S. Steelman, Richard A. Franklin, Stephen L. Abrams, William H. Chappell, Christian Kempf, Jörg Bäsecke, Franca Stivala, Marco Donia, Paolo Fagone, Ferdinando Nicoletti, Massimo Libra, Peter P. Ruvolo, Vivian Ruvolo, Camilla Evangelisti, Alberto M. Martelli, James A. McCubrey	203
15	"What? So What?" The Next-Generation JHOVE2 Architecture for Format-Aware Characterization. 2008 ·SHILAP Revista de lepidopterología ·Stephen L. Abrams, (unknown), (unknown)	3
16	Emergency Management Planning as Collaborative Community Work 2008 ·Journal of Homeland Security and Emergency Management ·(unknown), John M. Carroll, Steven R. Haynes, Stephen L. Abrams	44
17	Contributions of the Raf/MEK/ERK, PI3K/PTEN/Akt/mTOR and Jak/STAT pathways to leukemia 2008 ·Leukemia ·Linda S. Steelman, Stephen L. Abrams, Jarrett T. Whelan, F. E. Bertrand, (unknown), Jörg Bäsecke, Massimo Libra, Franca Stivala, Michèle Milella, Agostino Tafuri, Paolo Lunghi, Antonio Bonati, Alberto M. Martelli, James A. McCubrey	301
18	Synergy between an IGF-1R antibody and Raf/MEK/ERK and PI3K/Akt/mTOR pathway inhibitors in suppressing IGF-1R-mediated growth in hematopoietic cells 2006 ·Leukemia ·F. E. Bertrand, Linda S. Steelman, William H. Chappell, Stephen L. Abrams, J G Shelton, (unknown), Dale L. Ludwig, James A. McCubrey	68
19	PDF/A: An Electronic Document File Format for Long-Term Preservation 2004 ·Archiving Conference ·Stephen L. Abrams, (unknown)	4
20	The National Engineering Education Delivery System: A Digital Library for Engineering Education [and] Reference Linking in a Hybrid Library Environment (Part 1: Frameworks for Linking & Part 2:SFX, a Generic Linking Solution) [and] The State of the Dublin Core Metadata Initiative [and] Distributed Information and Computation in Scientific and Engineering Environments. 1999 ·D-Lib Magazine ·Brandon Muramatsu, Alice M. Agogino, Herbert Van de Sompel, (unknown), Stuart Weibel, Nicholas M. Patrikalakis, Paul Fortier, Yannis Ioannidis, Christos Nikolaou, Allan R. Robinson, Jarek Rossignac, Àlvar Vinacua, Stephen L. Abrams	4

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact